Literature DB >> 2709375

New hydrogen-bond potentials for use in determining energetically favorable binding sites on molecules of known structure.

D N Boobbyer1, P J Goodford, P M McWhinnie, R C Wade.   

Abstract

An empirical energy function designed to calculate the interaction energy of a chemical probe group, such as a carbonyl oxygen or an amine nitrogen atom, with a target molecule has been developed. This function is used to determine the sites where ligands, such as drugs, may bind to a chosen target molecule which may be a protein, a nucleic acid, a polysaccharide, or a small organic molecule. The energy function is composed of a Lennard-Jones, an electrostatic and a hydrogen-bonding term. The latter is dependent on the length and orientation of the hydrogen bond and also on the chemical nature of the hydrogen-bonding atoms. These terms have been formulated by fitting to experimental observations of hydrogen bonds in crystal structures. In the calculations, thermal motion of the hydrogen-bonding hydrogen atoms and lone-pair electrons may be taken into account. For example, in a alcoholic hydroxyl group, the hydrogen may rotate around the C-O bond at the observed tetrahedral angle. In a histidine residue, a hydrogen atom may be bonded to either of the two imidazole nitrogens and movement of this hydrogen will cause a redistribution of charge which is dependent on the nature of the probe group and the surrounding environment. The shape of some of the energy functions is demonstrated on molecules of pharmacological interest.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2709375     DOI: 10.1021/jm00125a025

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  53 in total

1.  Computer based screening of compound databases: 1. Preselection of benzamidine-based thrombin inhibitors.

Authors:  T Fox; E E Haaksma
Journal:  J Comput Aided Mol Des       Date:  2000-07       Impact factor: 3.686

2.  A comparative docking study and the design of potentially selective MMP inhibitors.

Authors:  S Hanessian; N Moitessier; E Therrien
Journal:  J Comput Aided Mol Des       Date:  2001-10       Impact factor: 3.686

3.  Functional group placement in protein binding sites: a comparison of GRID and MCSS.

Authors:  R Bitetti-Putzer; D Joseph-McCarthy; J M Hogle; M Karplus
Journal:  J Comput Aided Mol Des       Date:  2001-10       Impact factor: 3.686

4.  3D hydrogen bond thermodynamics (HYBOT) potentials in molecular modelling.

Authors:  Oleg A Raevsky; Vladlen S Skvortsov
Journal:  J Comput Aided Mol Des       Date:  2002-01       Impact factor: 3.686

5.  Q-fit: a probabilistic method for docking molecular fragments by sampling low energy conformational space.

Authors:  Richard M Jackson
Journal:  J Comput Aided Mol Des       Date:  2002-01       Impact factor: 3.686

6.  3D QSAR studies on binding affinities of coumarin natural products for glycosomal GAPDH of Trypanosoma cruzi.

Authors:  Irwin R A Menezes; Julio C D Lopes; Carlos A Montanari; Glaucius Oliva; Fernando Pavão; Marcelo S Castilho; Paulo C Vieira; Mônica T Pupo
Journal:  J Comput Aided Mol Des       Date:  2003 May-Jun       Impact factor: 3.686

7.  Automated site-directed drug design: the generation of a basic set of fragments to be used for automated structure assembly.

Authors:  P L Chau; P M Dean
Journal:  J Comput Aided Mol Des       Date:  1992-08       Impact factor: 3.686

8.  STRIDE: a web server for secondary structure assignment from known atomic coordinates of proteins.

Authors:  Matthias Heinig; Dmitrij Frishman
Journal:  Nucleic Acids Res       Date:  2004-07-01       Impact factor: 16.971

9.  Gaussian mapping of chemical fragments in ligand binding sites.

Authors:  Kun Wang; Marta Murcia; Pere Constans; Carlos Pérez; Angel R Ortiz
Journal:  J Comput Aided Mol Des       Date:  2004-02       Impact factor: 3.686

10.  Automated site-directed drug design: approaches to the formation of 3D molecular graphs.

Authors:  R A Lewis
Journal:  J Comput Aided Mol Des       Date:  1990-06       Impact factor: 3.686

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.